Top 50 Medical Device VC Funds & Investors in France (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bpifrance
VC Fund
|
23 | France, United States, Switzerland | Seed, Series A | Software, Information Technology, Health Care | $658k–$35M |
|
GO CAPITAL
VC Fund
|
13 | France, Canada, Israel | Seed, Series A | Biotechnology, Software, Health Care | $516k–$10M |
|
Karista
VC Fund
|
11 | France, United States, Finland | Seed, Series A, Series B | Software, Biotechnology, Health Care | $713k–$43M |
|
Elaia
VC Fund
|
11 | France, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.1M–$38M |
|
Sofimac Investment Managers
VC Fund
|
10 | France, Italy, Austria | Seed, Series A | Biotechnology, Health Care, Manufacturing | $274k–$15M |
|
Seventure Partners
VC Fund
|
10 | France, United States, Germany | Series A, Series B | Biotechnology, Software, Health Care | $3.1M–$65M |
|
Sofinnova Partners
VC Fund
|
9 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$102M |
|
Angels Santé
VC Fund
|
9 | France, India, United States | Seed, Angel | Health Care, Biotechnology, Medical Device | $658k–$3.4M |
|
Kurma Partners
VC Fund
|
9 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$80M |
|
IRDI
VC Fund
|
9 | France | Series A, Seed | Health Care, Software, Biotechnology | $1.6M–$22M |
|
M Capital Partners
VC Fund
|
8 | France, United States, Canada | Seed, Series A | Health Care, Software, Food and Beverage | $1.1M–$7.7M |
|
Crédit Agricole
VC Fund
|
7 | France, United States, Italy | Seed, Debt Financing | Energy, Software, Health Care | $768k–$1.3B |
|
Newfund
VC Fund
|
7 | France, United States, Canada | Seed, Series A | Software, Information Technology, SaaS | $1.1M–$15M |
|
Idinvest Partners
VC Fund
|
6 | France, United States, Spain | Series B, Series A | Biotechnology, Health Care, Software | $3.3M–$66M |
|
Omnes Capital
VC Fund
|
6 | France, Germany, United States | Series A, Series B | Software, Biotechnology, Health Care | $3.5M–$43M |
|
BNP Paribas Développement
VC Fund
|
6 | France, Germany, The Netherlands | Series A, Seed | Software, Health Care, Information Technology | $2M–$23M |
|
UI Investissement
VC Fund
|
6 | France, Spain, Canada | Private Equity, Series A, Seed | Manufacturing, Software, Health Care | $1.5M–$49M |
|
IRDI SORIDEC Gestion
VC Fund
|
5 | France, Brazil, Singapore | Seed, Series A | Software, Biotechnology, Medical | $1.6M–$13M |
|
iBionext
VC Fund
|
5 | France | Series A, Seed | Medical Device, Artificial Intelligence, Drones | $7.7M–$15M |
|
WiSEED
VC Fund
|
5 | France | Seed, Equity Crowdfunding | Software, Manufacturing, Biotechnology | $384k–$3.3M |
|
Finovam Gestion
VC Fund
|
5 | France, United States | Seed, Series A | Software, Information Technology, Medical Device | $505k–$3.9M |
|
Supernova Invest
VC Fund
|
5 | France, United States, Israel | Series A, Series B | Manufacturing, Health Care, Medical Device | $6M–$58M |
|
Galia Gestion
VC Fund
|
4 | France, United States | Series A, Seed | Software, Manufacturing, Biotechnology | $531k–$6.9M |
|
Nord France Amorcage
VC Fund
|
4 | France, United States | Seed, Series A | Software, Information Technology, Medical | $329k–$25M |
|
Inserm Transfert Initiative
VC Fund
|
4 | France, Switzerland, United States | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $1.1M–$60M |
|
Sham Innovation Santé
VC Fund
|
3 | France | Series B, Series A | Biotechnology, Medical Device, Medical | $5.7M–$80M |
|
Région Sud Investissement
VC Fund
|
3 | France, Spain | Seed, Series A | Software, Information Technology, Manufacturing | $1.1M–$22M |
|
Sodero Gestion
VC Fund
|
3 | France | Seed, Series A | Software, Information Technology, Telecommunications | $219k–$6.6M |
|
AQUITI Gestion
VC Fund
|
3 | France, United States | Series A, Seed | Biotechnology, Software, Manufacturing | $170k–$18M |
|
Polytechnique Ventures
VC Fund
|
3 | France, United Kingdom, United States | Seed, Series A | Biotechnology, Robotics, Information Technology | $2.1M–$17M |
|
Kima Ventures
VC Fund
|
3 | France, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, SaaS, Artificial Intelligence | $549k–$16M |
|
MD Start
VC Fund
|
3 | France | Seed, Series B | Medical Device, Health Care, Medical | |
|
Capital Grand Est
VC Fund
|
3 | France | Series A, Seed | Health Care, Biotechnology, Medical Device | $1.2M–$19M |
|
Pontifax
VC Fund
|
3 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $4M–$104M |
|
XAnge
VC Fund
|
3 | France, Germany, Belgium | Series A, Seed, Series B | Software, SaaS, E-Commerce | $1.1M–$60M |
|
IT-Translation
VC Fund
|
3 | France | Seed, Series A | Software, SaaS, Machine Learning | $329k–$5.5M |
|
MACSF
VC Fund
|
3 | France, Spain, Ecuador | Series A, Seed | Health Care, Medical, Medical Device | $1.1M–$44M |
|
Mérieux Equity Partners
VC Fund
|
3 | France, United States, Belgium | Series A, Private Equity | Health Care, Biotechnology, Medical Device | $5.8M–$150M |
|
ACG Management
VC Fund
|
3 | France, Madagascar | Seed, Series A | Software, Health Care, Biotechnology | $878k–$7.2M |
|
Auriga Partners
VC Fund
|
3 | France, United States, Switzerland | Series B, Series A | Biotechnology, Health Care, Medical | $2.2M–$33M |
|
Crédit Mutuel Innovation
VC Fund
|
3 | France, United States, Canada | Series A, Series B | Software, Health Care, Biotechnology | $3.3M–$43M |
|
Pays de la Loire Participations
VC Fund
|
3 | France | Seed, Private Equity | Manufacturing, Software, Information Technology | $549k–$3.3M |
|
NACO
VC Fund
|
3 | France | Seed, Series A | Health Care, Medical Device, Information Technology | $658k–$11M |
|
Cap Innov'Est
VC Fund
|
3 | France, United States | Seed, Series A | Biotechnology, Medical, Health Care | $549k–$7.7M |
|
HCVC
VC Fund
|
2 | United States, France, United Kingdom | Seed, Series A, Pre-Seed | Software, Robotics, Artificial Intelligence | |
|
LivaNova
VC Fund
|
2 | France, United States | Series B, Series A | Medical Device, Health Care, Medical | $17M–$35M |
|
IXO Private Equity
VC Fund
|
2 | France, United States, Canada | Private Equity, Series A | Health Care, Manufacturing, Biotechnology | |
|
Majycc eSanté Invest
VC Fund
|
2 | France | Seed, Series A, Series B | Health Care, Fitness, Computer | |
|
Techmind
VC Fund
|
2 | France, Senegal | Seed, Series A | Software, SaaS, Information Technology | |
|
Atlantique Vendée Innovation
VC Fund
|
2 | France | Seed | AgTech, Medical, Medical Device | |
| Access all 409 VC funds in France Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 988
- Round size: Seed $658k–$6.4M; Series A $2.5M–$35M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- May Health — May Health is developing a modern treatment - Ovarian Rebalancing - designed to restore ovulation for people with polycystic ovary syndrome.
- Callyope — Callyope is building the first speech-based foundational model to monitor mental health symptoms through low-touch smartphone interactions.
- Smile Wanted Group — Spot the most valuable inventory on premium websites and provide guarantees of performance to advertisers. Reach +500M users /month globally.
GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series A
- Geography: France, Canada, Israel
Investor stats
- Total investments: 130
- Round size: Seed $516k–$6.6M; Series A $2.1M–$10M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Episto — Episto helps you collect ultra-authentic insights from your targets, anywhere in the world, simply and instantly
- AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
- Axomove — Axomove is an e-health app that specializes in video physical exercises.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, United States, Finland
Investor stats
- Total investments: 144
- Round size: Seed $713k–$6.6M; Series A $1.2M–$15M; Series B $2.5M–$43M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
- Stootie — Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick!This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime.The keywords of Stootie are : marketplace, P2P business, local,mobile, realtime, platform.Stootie is currently available on iOS and Android.
- Exotrail — Exotrail is an end-to-end space mobility operator. Our mission is to enable small satellites to move in space, optimise their deployment, increase their service performance, and reduce space pollution.
Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: France, United States, Spain
Investor stats
- Total investments: 210
- Round size: Seed $1.1M–$9.9M; Series A $2.2M–$27M; Series B $4.2M–$38M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Elevo — Elevo is a Paris-based performance management platform.
- Vibe — Advertise your brand on CTV & OTT content with Vibe's self-serve ad platform to target hundreds of channels & networks and reach millions of households.
- Traefik Labs — Cloud-native, GitOps-driven API runtime solutions for demanding DevOps and Platform Engineers with diverse use-cases, environments, and deployment models.
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: France, Italy, Austria
Investor stats
- Total investments: 73
- Round size: Seed $274k–$2M; Series A $1.6M–$15M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
- Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
- Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 213
- Round size: Series A $3.1M–$24M; Series B $3.3M–$65M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Otoqi — Otoqi is a vehicle delivery platform that develops connected services and logistics solutions for the automotive professionals.
- Karmen — Karmen offers revenue-based financial solutions such as venture capital and loans to accelerate business growth for SaaS companies.
- Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 298
- Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Angel
- Geography: France, India, United States
Investor stats
- Total investments: 34
- Round size: Seed $1.1M–$3.4M; Angel $658k–$1.3M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
- Odimma — Empowering personalized immunotherapy to treat cancer
- AUSTRAL Dx — Austral Dx develops contactless AI technology for rapid cardiopulmonary diagnostics, helping clinicians identify life-threatening conditions faster in emergency care.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 128
- Round size: Seed $2.3M–$13M; Series A $3.8M–$74M; Series B $8.8M–$80M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
IRDI Gestion aims to participate in the economic growth and job creation in their regions. For this, their teams create a real partnership with the companies they accompany, based on a relationship of trust and proximity.IRDI Gestion currently manages €150 million and has financial tools able to accompany the Southwest SMEs in the creationphase, development or transmission, with intervention tickets from equity € 100000 to € 5000000.Precursor of regional investment capital of the Southwest, with a presence of over 35 years, the IRDI Group consists of 3 SCR:- IRDI, created in 1981 to foster industrial growth companies based in the South West of France- MPcroissance, created in 1996 to assist small businesses in Midi-Pyrénées- IRDInov, created in 2012 under the leadership of the National Seed Fund (under the PIA) to fund the initiation of innovative companiesIn 2015, the management company IRDI Gestion, approved by the AMF, was formed to structure the group and bring new development projects.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed
- Geography: France
Investor stats
- Total investments: 43
- Round size: Seed $1.9M–$9.2M; Series A $1.6M–$22M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
- Starfish Bioscience — STARFISH Bioscience focuses on the creation and development of microbiological solutions for agriculture and vineyards. Our objective is to regenerate soils by restoring their microbiomes, increasing sustainability and productivity while minimizing environmental impact. We are dedicated to improving humanity's well-being and preserving theearth by inventing technologies that address the future difficulties of global agriculture.
- Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.
Show more...Investment focus
- Industry: Health Care, Software, Food and Beverage
- Stage:Seed, Series A
- Geography: France, United States, Canada
Investor stats
- Total investments: 108
- Round size: Seed $1.1M–$5.2M; Series A $3.3M–$7.7M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Hakbah — Hakbah is a Fintech startup focusing on an alternative financial saving. Hakbah is modernizing financial saving via its intelligent platform by offering a comprehensive one-stop-shop solution for Savings Groups to initiate, manage, join, and pay directly within the mobile app.
- Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.
- The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.
Show more...Investment focus
- Industry: Energy, Software, Health Care
- Stage:Seed, Debt Financing
- Geography: France, United States, Italy
Investor stats
- Total investments: 131
- Round size: Seed $768k–$4.4M; Debt Financing $1.6M–$1.3B
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Fortum — By providing our customers and the Nordic energy system with a supply of reliable energy, we aim to power a world where people, businesses, and nature thrive together. With respect for the environment, decades of expertise and smart solutions, we strive to meet our customers' needs.
- FlowPay — Open banking & payment solutions. FlowPay supporta la tua azienda nei flussi di incasso e pagamento con soluzioni innovative integrabili via API.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
Newfund is a $300M entrepreneurial VC firm dedicated to pre-seed and seed investments in France and North America, in companies driving global change. The company is always looking for founders who are driven to realize a vision that will significantly alter the world in which we live. In order to appreciate what entrepreneurs are creating andutilize their strengths, Newfund aims to comprehend entrepreneurs as unique individuals.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A
- Geography: France, United States, Canada
Investor stats
- Total investments: 171
- Round size: Seed $1.1M–$6M; Series A $2.2M–$15M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Aveine — Discover the Aveine wine aerator for perfect and instantaneous wine aeration. Already approved by sommeliers, oenologists and chefs.
- Reecall — Reecall is an IT firm that provides AI-based call management services.
- Volum — Volum offers an innovative office real estate solution for both tenants and owners. Its digital platform manages all aspects of property rental for companies, from the search for offices to the signing of the rental contract, including any work, fittings, equipment and associated services (IT, maintenance, surveillance, reception, etc.). Byregistering on Volum’s platform, companies also benefit from a more flexible rental contract.
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A
- Geography: France, United States, Spain
Investor stats
- Total investments: 252
- Round size: Series A $3.3M–$24M; Series B $7.8M–$66M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $88M in 2021
Portfolio highlights
- Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
- Glovo — Glovo delivers the best products of your city in less than 1 hour
- Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Series B
- Geography: France, Germany, United States
Investor stats
- Total investments: 173
- Round size: Series A $3.5M–$37M; Series B $4.4M–$43M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $403M in 2020
Portfolio highlights
- VSORA — VSORA provides high performance companion solutions combining AI and signal processing to enable autonomous driving and ADAS
- Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
- Amakem — Easy, affordable options for you to obtain the domain you want. Safe and secure shopping.
BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 134
- Round size: Seed $2M–$10M; Series A $3.8M–$23M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
- Endodiag — Endodiag specializes in the development of products and services that improves the diagnosis of endometriosis. Endodiag takes part in endometriosis research by developing diagnosis solutions focused on patient screening and individual endometriosis characteristics.
- BeFC Bioenzymatic Fuel Cells — Miniature batteries are complex, expensive and unecological to collect and recycle. Our thin, light-weight and flexible paper-based biofuel cells are biodegradable, environmentally friendly and economically viable.
Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Private Equity, Series A, Seed
- Geography: France, Spain, Canada
Investor stats
- Total investments: 98
- Round size: Seed $1.5M–$7.1M; Series A $2.9M–$33M; Private Equity $3.1M–$49M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $37M in 2021
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Fizimed — Fizimed has made the choice to develop the EMY perineal probe with recognized health professionals. The probe is connected to a mobile app and associated with custom exercises. The probe captures the contractions of the perineal muscles in real time to allow the patient to do 5-minute exercises through fun games (jumping obstacles, jumping ...) sothat she remains motivated. The patient can follow her results as well as her progress in the application and unlock new universes according to the points obtained. Much of the effort of Fizimed's technical teams is focused on balancing a product, combining the quality and safety of a medical device, with a fun application to empower each woman. One goal: the simplicity of the product and the interface for home use.Beyond the product, the Fizimed team is committed to the fight against taboos related to urinary incontinence problems affecting one in ten women. She wants to "demystify" this topic so that every woman can find her adapted solution. An EMY community is being born on social networks in which the feminine hassles are put into images and discussed with humor, while talking about innovations that can simplify their daily lives.In summary, EMY by Fizimed is the connected and fun medical probe that allows women wishing to regain control of their perineum to do their home exercises. It was developed by a dynamic Alsatian start-up whose ambition is to remove taboos on a public health issue.
- Fungu'it — A new generation of flavor ingredients for healthy, sustainable, and accessible food.
IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: France, Brazil, Singapore
Investor stats
- Total investments: 51
- Round size: Seed $1.6M–$5.8M; Series A $3.7M–$13M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
- Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
- DiappyMed — DiappyMed specializes in developing platforms to calculate insulin dosages.
iBionext is a unique healthcare fund created within a proven breakthrough innovation accelerator. Their companies are based in a single location named “Passage de l’innovation” in Paris, France. Over the past 4 years, we have created 7 companies that have raised over 250M € and created 103 highly qualified jobs.
Show more...Investment focus
- Industry: Medical Device, Artificial Intelligence, Drones
- Stage:Series A, Seed
- Geography: France
Investor stats
- Total investments: 13
- Round size: Series A $7.7M–$15M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $105M in 2018
Portfolio highlights
- Prophesee — REVEAL THE INVISIBLE with the world's most advanced neuromorphic vision system, inspired by human vision and built on the foundation of neuromorphic engineering. PROPHESEE gives Metavision to machines, revealing what was previously invisible to them.
- GrAI Matter Labs — GrAI Matter Labs has created the fastest edge AI processor for machine vision in robotics, AR/VR, drones and more. It achieves ultra-low latency at low power by leveraging sparsity.
- Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more...Investment focus
- Industry: Software, Manufacturing, Biotechnology
- Stage:Seed, Equity Crowdfunding
- Geography: France
Investor stats
- Total investments: 30
- Round size: Seed $384k–$3.3M; Equity Crowdfunding $466k–$2.7M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
- Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.
Show more...Investment focus
- Industry: Software, Information Technology, Medical Device
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 32
- Round size: Seed $505k–$3.9M; Series A $549k–$3.8M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Nijta — You have tons of speech data but handling it is a compliance minefield. Leverage the power of Nijta's AI-based voice anonymisation to use your data at scale without compromising privacy and confidentiality.
- Selvitys — Selvitys is a fully automated method for designing, delivering, and analyzing online surveys.
- BiblioOnDemand — BiblioOnDemand is a provider of digital library services that offer a diverse selection of ebooks and audiobooks.
we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Medical Device
- Stage:Series A, Series B
- Geography: France, United States, Israel
Investor stats
- Total investments: 95
- Round size: Series A $6M–$30M; Series B $7.7M–$58M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Fyteko — For a more sustainable agriculture
- ANYbotics — ANYbotics provides autonomous legged robots for industrial applications to provide high availability and reliability in automated routine inspections.
- Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more...Investment focus
- Industry: Software, Manufacturing, Biotechnology
- Stage:Series A, Seed
- Geography: France, United States
Investor stats
- Total investments: 55
- Round size: Seed $531k–$2.9M; Series A $849k–$6.9M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $21M in 2013
Portfolio highlights
- Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
- Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Nord France Amorçage is a regional co-investment fund, exclusively supported by the Hauts-de-France Region. This seed fund has been involved since 2013 in financing innovative businesses that create jobs and add value to the region. In 6 years, NFA has more than 50 participants spread across the region.
Show more...Investment focus
- Industry: Software, Information Technology, Medical
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 32
- Round size: Seed $329k–$2.5M; Series A $1.1M–$25M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- NeoCem — NeoCem creates, manufactures, and promotes a variety of low-carbon cements for the building industry. They have developed a novel procedure that permits the utilization of raw materials sourced from recovery sectors.
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
- Energo — To reduce global warming, Energo has developed an innovative technology to convert gases into molecules of interested at high added value
Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: France, Switzerland, United States
Investor stats
- Total investments: 21
- Round size: Seed $2.7M–$3.6M; Series A $1.1M–$35M; Series B $2.2M–$60M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
- VectivBio — Explore Ironwood Pharmaceuticals' commitment to GI health with innovative therapies, patient-focused research, and a vision to improve digestive disease treatment.
- Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.
Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Medical
- Stage:Series B, Series A
- Geography: France
Investor stats
- Total investments: 16
- Round size: Series A $5.7M–$74M; Series B $9.9M–$80M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
- Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Région Sud Investissement is an investment Firm.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: France, Spain
Investor stats
- Total investments: 60
- Round size: Seed $1.1M–$5.8M; Series A $2.2M–$22M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Agriodor — Agriodor is to provide concrete and effective alternatives to insecticides to help farmers produce more sustainably.
- K-Motors — K-Motors develops modules that improve the battery cycle of electric vehicles and motors.
- MYCOPHYTO — Co-created in July 2016 by Justine LIPUMA, PhD in microbiology, and Christine PONCET-DOISE, Senior Research Engineer at INRA, MYCOPHYTO is the result of 30 years of experimentation in biological crop protection.
Sodero Management has 70 million of capital it intends to finance for SMEs. These funds come from the Caisse d'Epargne and Caisse des Depots et Consignations, firstly, of Brittany and Pays de la Loire, on the other. But also individuals from which € 26m was raised in 5 years through FIP (Local Investment Fund sold each year by the SavingsBank from November). And local savings will directly feed the local economy while enjoying immediate tax benefits.
Show more...Investment focus
- Industry: Software, Information Technology, Telecommunications
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 20
- Round size: Seed $219k–$2.2M; Series A $713k–$6.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Grimp — Saas solution to manage your job search in one place.
- D-ICE Engineering — D-ICE Engineering is a deeptech company that specializes in dynamic positioning, hydrodynamics, marine energy, A-I, and system engineering.
- BioMAdvanced Diagnostics — Online138 menghadirkan festival terbesar yang didalamnya terdapat hiburan online tanpa batas dengan bekerja sama bersama GGSoft yang paten dan gampang menang hari ini.
Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.
Show more...Investment focus
- Industry: Biotechnology, Software, Manufacturing
- Stage:Series A, Seed
- Geography: France, United States
Investor stats
- Total investments: 55
- Round size: Seed $170k–$5.8M; Series A $849k–$18M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $6.4M in 2010
Portfolio highlights
- Speeral — Speeral est la plateforme SaaS qui automatise le cycle complet de vente sur les marketplaces C2C et vous permet de tirer profit du canal.
- Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
- Amédia Solutions — Amédia Solutions is an IT service provider and telecom operator. It is a local player specializing in B to B IT and telecoms. It has thus been able to forge various strong partnerships with publishers, manufacturers, infrastructure operators, security specialists to offer the best of IT and telecommunications.
Polytechnique Ventures support entrepreneurs from the School's ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Robotics, Information Technology
- Stage:Seed, Series A
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 21
- Round size: Seed $2.1M–$12M; Series A $7.9M–$17M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- bYoRNA — bYoRNA is a French biotechnology company specializing in the cost-efficient, scalable bioproduction of high-quality therapeutic messenger RNA (mRNA) using engineered eukaryotic cells, particularly recombinant yeast. Their disruptive platform enables the production of long, humanized mRNA with lower immunogenicity and higher integrity compared totraditional in vitro enzymatic synthesis. This technology aims to mass produce mRNA for gene therapies, cancer vaccines, and infectious disease vaccines at a fraction of current costs, making mRNA therapeutics more accessible globally.
- Jimmy — Jimmy is a supplier of carbon-free industrial heat to industrialists. The company designs and markets turnkey thermal generators, connected to the heating circuits of factories. These generators rely on a nuclear micro-reactor to create heat.
- One Biosciences — One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases. Magali Richard, David Schilansky, and Céline Vallot co-founded the company in Paris, Ile-de-France, France.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Kima Ventures promotes the growth of startups, supporting them in the fastest and most effective ways.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 523
- Round size: Seed $549k–$5.5M; Pre-Seed $560k–$4.4M; Series A $1.1M–$16M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Dialog — Dialog is the AI shopping assistant that transforms conversations into conversions, giving each shopper a tailored, in-store experience online.
- Explora Project — Explora Project is specializing in adventure travel and expeditions to the 4 corners of the planet and all environments.
- Flow Engineering — Requirements management, made collaborative
MD Start is an incubator and fund dedicated to medical technologies. MD Start creates, develops, and operates medical projects, turning them into new companies with both strategic and hands-on approaches, in order to bring them to investment stage and commercial development.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Seed, Series B
- Geography: France
Investor stats
- Total investments: 4
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- HEPTA Medical — HEPTA Medical develops a sensor, embedded into a bronchoscopic or percutaneous ablation catheter, which provides temperature-based feedback. This enables real-time dosing to precisely target and ablates pulmonary nodules, the precursor of lung cancer, without the need for surgery or radiation.
- Gradient Denervation Technologies — First purpose-built, minimally invasive, ultrasound-based system designed to treat patients with pulmonary hypertension due to left-sided heart disease.
Capital Grand Est is a private equity firm that focuses on supporting businesses. Capital Grand Est was founded in 2012 and was headquartered in Schiltigheim, France.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed
- Geography: France
Investor stats
- Total investments: 11
- Round size: Seed $1.2M–$3.4M; Series A $2.6M–$19M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- SEEQLE — Seeqle is an AI-driven recruitment and talent acquisition platform founded in 2018 and headquartered in Nancy and Paris. By seamlessly integrating programmatic advertising with advanced candidate pre-screening, Seeqle empowers HR teams and training organizations to automate the entire hiring lifecycle—from crafting hyper-targeted campaigns (SeeqleTalent Ads) across 2 million+ web, social, video and audio channels, to enriching, scoring and predicting candidate success with its CRM/ATS module (Seeqle Talent CRM). Leveraging a proprietary dataset of 380 000+ socio-professional signals and continuous machine-learning refinements, Seeqle enables clients in 8 countries to attract up to 5× more qualified applicants, cut time-to-hire by over 50%, and maintain real-time budget optimization.Seeqle’s suite includes personality profiling (MBTI-style analysis), hidden-skill detection, career-path forecasting and automated rejection emails, all accessible via a unified dashboard. The company has raised €2.5 million to date, serves Fortune 500 clients and high-growth SMEs alike, and has earned five industry awards for its innovation in HR Tech. With plans to expand into North America and deepen its AI capabilities, Seeqle is redefining how organizations source, evaluate and engage talent at scale.
- SUPERBRANCHE — SUPERBRANCHE is a biotechnology company for the early detection and treatment of metastases through nanotechnological provisions.
- RDS — RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology isaimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies. The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings. The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians. In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology. Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Our main product, MultiSense®, is a comprehensive Remote Patient Monitoring Solution. MultiSense® offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond. MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards. MultiSense® has been validated by 6 completed clinical investigations.RDS relies on a talented and international team with deep subject-matter-expertise and a proven track record in the Healthcare and Medical Device sector. At RDS, we all share the same passion for bringing patient pathways to the next level.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 106
- Round size: Series A $4M–$95M; Series B $20M–$100M; Series C $12M–$104M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: France, Germany, Belgium
Investor stats
- Total investments: 210
- Round size: Seed $1.1M–$8M; Series A $3M–$22M; Series B $6M–$60M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $234M in 2021
Portfolio highlights
- Tomorro — Leeway helps you reduce the time spent on contract management and gives you more control and visibility over legal and financial risks.
- Request Finance — A suite of financial tools to make your life easier - crypto organizations & freelancers use Request for invoices, expenses, payroll or accounting.
- POLLEN Metrology — The revolution of artificial intelligence for high performance materials. Accelerate the time to yield of new materials and processes.
IT-Translation: investor and co-founder of digital technology start-ups developed from research
Show more...Investment focus
- Industry: Software, SaaS, Machine Learning
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 13
- Round size: Seed $329k–$768k; Series A $549k–$5.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AntsRoute — AntsRoute is a cloud-based route planning & optimization software developed by the French startup Antsway in 2015. The solutions help professionals to create optimal delivery, pick-up and multi-stop routes. The routing software makes it easier to smartly schedule appointments, optimize daily routes, automate dispatch to drivers, track theirprogress in real-time and keep customers updated with SMS alerts. The best software to increase stops per route, cut down transport costs and planning time.
- Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
- Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
Mutuelle d'Assurance du Corps de Santé Français (MACSF) is the provider of insurance to health professionals. MACSF protects and accompanies 950,000 members of all medical and paramedical specialties, offering professional and personal solutions in insurance, savings, financing, and pensions. Its products and services meet the real needs ofits members by accompanying them in the evolution of their profession and their projects.MACSF was founded in 1935.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Seed
- Geography: France, Spain, Ecuador
Investor stats
- Total investments: 24
- Round size: Seed $1.1M–$24M; Series A $7.7M–$44M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
- Singulier — Singulier partners with global private equity funds and portfolio companies from due diligence to transformation.
- Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Private Equity
- Geography: France, United States, Belgium
Investor stats
- Total investments: 57
- Round size: Series A $5.8M–$22M; Private Equity $22M–$150M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $417M in 2020
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
- CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: France, Madagascar
Investor stats
- Total investments: 49
- Round size: Seed $878k–$2.9M; Series A $1.5M–$7.2M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $15M in 2013
Portfolio highlights
- Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
- Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
- My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.
Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 128
- Round size: Series A $2.2M–$14M; Series B $3.8M–$33M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Amplitude — Amplitude is a leading manufacturer of femtosecond lasers. We are laying the foundations for advances in science, industry, and health care.
- Pherecydes Pharma — Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to itsouter membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.
- Median Technologies — We harness the power of Imaging Phenomics to contribute to the development of next generation treatments and care strategies for patients in need.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: France, United States, Canada
Investor stats
- Total investments: 88
- Round size: Series A $3.3M–$27M; Series B $6.7M–$43M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- iskn — Explore iskn's smart solutions for individuals and teams. Enhance creativity, productivity, and digital collaboration across workspaces worldwide.
- NEOBRAIN — Neobrain offers transformation support platforms that meet three needs within organisations: employee commitment and loyalty; simplification and fluidity of mobility; alignment of employee skills with the company's strategy.
- Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
Pays de la Loire Participations provides finance innovation, productivity and development, especially in a banking context that is increasingly constrained by standards and regulations.The Pays de la Loire region has created the "Pays de la Loire Participations" co-investment fund (PLP) intended for small and medium-sized companieswishing to strengthen their equity. By investing alongside private professional investors, it facilitates risk taking and helps anchor long-term skills on the territory and promotes job creation and wealth.With 14 million euros in capital (20 million in the long term), entirely contributed by the Region, the "Pays de la Loire Participations" fund co-invested an average of around 2.5 million euros annually. average of € 180 K per company. Its intervention as a co-investor is crucial because it allows the VSE / SME beneficiaries to obtain from private financiers and banks, 4 times the funds contributed by Pays de la Loire participations.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Seed, Private Equity
- Geography: France
Investor stats
- Total investments: 48
- Round size: Seed $549k–$3.3M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Tract'Moi — Tract'Moi is a producer of farming equipment for farmers seeking independence and adaptability.
- Miura Simulation — Miura helps engineers take control of their data, connect tools, reduce vendor friction, and lay the foundation for scalable AI.
- D-ICE Engineering — D-ICE Engineering is a deeptech company that specializes in dynamic positioning, hydrodynamics, marine energy, A-I, and system engineering.
NACO is a co-investment fund for start-ups and small and medium-sized businesses (SMEs). NACO is a regional co-investment fund backed by Région Nouvelle-Aquitaine and managed by M/Capital Partners.
Show more...Investment focus
- Industry: Health Care, Medical Device, Information Technology
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 18
- Round size: Seed $658k–$4.1M; Series A $4.4M–$11M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- DESKi — HeartFocus is an AI-powered heart exam software for ultrasound and can be used with any hand-held probe, cart or ultrasound system. The product is available as an APP or SDK and is appropriate for clinics, health systems and learning institutions
- Praysbee — Praysbee is a French agri-tech startup that develops innovative, environmentally friendly spraying systems for vineyards. Their main product, the Wulp® boom, reduces chemical drift by over 90%, helping winegrowers spray more precisely and sustainably.
- Nova Carbon — The most performant sustainable carbon fiber material.
Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 18
- Round size: Seed $549k–$2.7M; Series A $7.5M–$7.7M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $42M in 2014
Portfolio highlights
- PeptiMimesis — PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of peptidomimetic candidates interfering with the hetero- and/or the homodimerization of target receptors.PeptiMimesis will develop its pipeline against keytargets in the fields of oncology, immuno-oncology and immune disease and is open to initiate collaboration with pharma partners on receptors of interest.
- Inoviem Scientific — Our groundbreaking label-free technologies enable you to detect and identify the clinical power of, and weaknesses in, your compound from early-stage pre-clinical R&D through to clinical trials
- Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.
Show more...Investment focus
- Industry: Software, Robotics, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 81
- Lead/follow: no public data
Portfolio highlights
- Karman+ — Mining near Earth asteroids
- Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
- Orakl Oncology — Cultivated with love by the Orakl team.
LivaNova is a global medical device company creating neuromodulation devices and cardiopulmonary products to improve the lives of patients around the world.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Series B, Series A
- Geography: France, United States
Investor stats
- Total investments: 4
- Round size: Series B $17M–$35M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ceribell — Triage and continuously monitor hospital patients at risk for seizures in minutes with Ceribell's point-of-care EEG solution. Learn more.
- HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
- Noctrix Health — Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Private Equity, Series A
- Geography: France, United States, Canada
Investor stats
- Total investments: 64
- Lead/follow: no public data
Portfolio highlights
- Indy — Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming.
- Wecasa — Wecasa is a data-driven marketplace that revolutionizes care services by focusing on user experience for customers and professionalsWecasa's mission is to make care services simple and accessible for a better quality of life. Through its app, users can book in seconds a reliable Professional for care services at home: wellness (haircut,beauty, massage), cleaning, and childcare. Available in Paris, top cities in France, London, and more European cities to come. Wecasa is proud to help 100.000+ customers and increase the business of 3000 independent professionals.
- Farmitoo — Farmitoo is an online purchase of farm equipment directly from manufacturers.
Majycc eSanté Invest is an investment firm
Show more...Investment focus
- Industry: Health Care, Fitness, Computer
- Stage:Seed, Series A, Series B
- Geography: France
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- Brightflow — Brightflow operates as a medical device startup.
- Archeon — Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and treatment of critically ill patients in prehospital care.
- NaoX Technologies — The tiniest medical grade connected solutions for the prevention of neurological disorders. An EEG On the Go. In-Ear EEG Medical Grade. by Naox Technologies.
Venture Capital investors
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: France, Senegal
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Groover — Groover is the best way to promote your music to blogs, radios, record labels, & Spotify playlisters. Get listened to, receive coverage & guaranteed feedback!
- Pixacare — B2B Saas for monitoring cutaneous diseases
- XXII GROUP — AI Vision Software
Atlantique Vendée Innovation is an investment firm based in France
Show more...Investment focus
- Industry: AgTech, Medical, Medical Device
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Starbolt — Starbolt offers electric bikes to employees and even businesses in order to activate mobility. They also provide repair and maintenance services for the products. The company's contact mode is at its physical address.
- D-ICE Engineering — D-ICE Engineering is a deeptech company that specializes in dynamic positioning, hydrodynamics, marine energy, A-I, and system engineering.
- BioMAdvanced Diagnostics — Online138 menghadirkan festival terbesar yang didalamnya terdapat hiburan online tanpa batas dengan bekerja sama bersama GGSoft yang paten dan gampang menang hari ini.
Medical Device VC funding in France at a glance
Stats across 382 deals from 409 investors.
Access all 409 VC funds in France Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 409 VC funds investing in France Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!